Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Asahi Kasei Licenses Eril to Eisai in South Korea
April 9, 2007
- Cook's Zenith AAA Endovascular Graft Reimbursed from April 1
April 9, 2007
- Kissei's MRs Provide Drug Safety Data on the Spot
April 9, 2007
- MEDICAL DEVICE NEWS IN BRIEF
April 9, 2007
- Alfresa Aims at 70% Share for Drugs for Narcolepsy with Modafinil
April 9, 2007
- Kobayashi Kako to Distribute Generics in Asian Countries
April 9, 2007
- Rep Track Survey: Anti-Allergy Drugs Enter Pollinosis Season
April 9, 2007
- GENERIC NEWS IN BRIEF
April 9, 2007
- Korosho Issues New Notifications to Accelerate Price Agreements
April 9, 2007
- Pfizer Enhances Sexual Harassment Measures in Response to Law Amendment
April 9, 2007
- Takeda Hired Largest No. of New Graduates in 2007
April 9, 2007
- TOPICS 3 articles
April 9, 2007
- BUSINESS NEWS IN BRIEF
April 9, 2007
- Eisai Aims at 7% Annual Growth in Domestic Market
April 9, 2007
- Zetia, Avastin, Adoair to Be Approved in April
April 9, 2007
- GL on Use of Tamiflu upon Onset of Avian Flu Need No Change: Council
April 9, 2007
- REGULATORY NEWS IN BRIEF
April 9, 2007
- Takeda, CanBas to Jointly Develop Anticancer Treatment
April 9, 2007
- Takeda, LGLS to Collaborate to Develop Anti-Obesity Drugs
April 9, 2007
- Takeda Acquires Full Rights to R-851 from 3M
April 9, 2007
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…